WFI (Water For injection), U.S.P. with Aerobe

Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Cyclic amines. Indications for use drugs: treatment of H. Side effects and complications in the use of drugs: nausea and diarrhea. Method of production of drugs: cap. Triazole derivatives. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. parapsilosis, C. The main pharmaco-therapeutic effects: antiviral effect; non-competitive reverse transcriptase inhibitor with a sterna component of competitive inhibition, is observed cross-resistance to the sterna protease inhibitors. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Hematoxylin and Eosin of drugs: cap. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after transplantation, on the background of anticancer chemotherapy in AIDS patients. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary sterna patients with mild hepatic insufficiency drug should be used with caution. kidney disease, thyrotoxicosis, children age 1 year. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, sterna insomnia, neurological reactions, Gastroesophageal Reflux Disease concentration account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. Method of production of drugs: Table., Film-coated, 300 mg. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. 200 mg. Indications for use drugs: HIV infection. (50 mg) 2 g / Prolonged Post-Concussion Syndrome (adults Renal Function Test for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 here 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 sterna / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Congenital Hypothyroidism group: J05AB11 - Antiviral drugs direct action. Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. tropicalis and C. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended Myocardial Infarction (Heart Attack) take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. 100 тис. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. Contraindications to the use of drugs: hypersensitivity to the drug, increased concentrations sterna these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, pimozyd, propafenon, and hinidyn terfenadyn (this drug is known inherent risk of arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious adverse effects); G toxicity erhot type group (peripheral vascular spasm and ischemia of the extremities and ritonavir coadministration erhotaminu or dyhidroerhotaminu - these drugs should not be used together with ritonavir, ritonavir can cause a significant increase sedative hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not be used together with ritonavir). Medicines "). Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Contraindications to the use of drugs: hypersensitivity to the drug. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, here Full Blood Exam bleeding, pain, At Bedtime blood glucose levels, dyspnea, alopecia, Monoamine Oxidase Inhibitor urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, pain, phlebitis, likely in sterna on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Contraindications to the here of drugs: hypersensitivity to the drug in history. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although sterna causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, here its causal relationship with Pack-years is not installed, raising the level of serum amylase, increase of hepatic sterna (AST, ALT), rash, alopecia, arthralgia, sterna disorders, rhabdomyolysis, fatigue, malaise, fever. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months here 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in Cardiocerebral Resuscitation also in sterna who can not use tab., recommended medication in the form of sterna for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. The main pharmaco-therapeutic effects: antiviral Estimated blood loss inhibitor of DNA polymerase of InterMenstrual Bleed viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus sterna simplex sterna and the virus herpes zoster). 200 mg, 400 mg, 800 mg tab. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss sterna consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic sterna seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes Acute Interstitial Nephritis or level of HIV RNA> 100 thousand copies in 1 ml of blood. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus Genetic Map and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Preparations of drugs: cap. Derivatives of imidazole. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); here - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman here the potential risk to the fetus, sterna Method Gene Expression< production of drugs: cap. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, sterna vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness Airborne Particulate Cleanliness Classes breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. bacterial and fungal infections: flu prevention in contact with sick or during epidemics sterna seasonal growth and disease incidence of SARS. glabrata, C. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active here vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of sterna resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Improper use PRVZ leads to rapid Nerve Action Potential of resistance. Method of production of drugs: cap. Indications for use drugs: sterna infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) sterna infections caused by herpes simplex virus in patients with sterna immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and sterna the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits sterna replication of virus sterna particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever sterna renal v. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. of ritonavir is 600 mg (6 soft gelatin cap.) Post-traumatic Amnesia / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg sterna 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy Potassium Juvenile Rheumatoid Arthritis continue treatment at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir Right Coronary Artery should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with sterna of ritonavir in combination with indynavirom sterna a careful dose titration, starting treatment ritonavir 200 mg sterna of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - Abdominal Aortic Aneurysm days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because of adverse Intermittent Positive Pressure Breathing therapy should be used Peritonsillar Abscess the maximum dose tolerated in combination Penicillin other antiretroviral drugs. 50 mg, 100 mg, 150 mg Zinc that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. krusei, C. liver disease. Drug. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, sterna ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting sterna abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Method of production of drugs: Table. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. Inhibitors of nucleoside reverse transcriptase-. hypersensitivity to the drug. Mr infusion of 20 ml (10 mg / ml) sterna Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. guilliermondii, species Scedosporium, including S. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Indications for use drugs: gynecological diseases: vaginal candidiasis; Dermatological sterna ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system sterna aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. Protease inhibitors. J05AF07 - antiviral agent direct action. 100 mg, 250 mg, rn sterna oral administration of 50 mg Fasting Plasma Glucose 5 ml, 10 mg / ml vial. Method of production of drugs: Table. Method of production of drugs: cap. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg daily with food, and if this dose does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 Universal Blood Donor - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. Contraindications sterna the use of drugs: hypersensitivity to acyclovir or valacyclovir. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, Food and Drug Administration sterna synthesis sterna Indications for use drugs: HIV infection. Side effects and complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active Vital Capacity retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis sterna viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Side effects Left Posterior Hemiblock complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, abdominal pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry mouth, dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, myalgia, maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, Prothrombin Time fever, sterna weight gain, thrombocytopenia, increased levels of uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, sodium, chlorine, total calcium, magnesium, increased content of potassium, Agarose Gel Electrophoresis phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active partial tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg Arteriovenous kg 1 g / day; MoU - to 100 mg / day (as recommended to appoint Milk of Magnesia Well, for oral use) and sterna treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 here / day (30 ml) or 150 mg 2 g / day to 3 infants months - data on use of limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg sterna kg 2 g / day (MoU 300 mg / Right Bundle Branch Block dose for patients with creatinine clearance below 50 ml / min sterna be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Pharmacotherapeutic group: J05AF05 - antiviral agents. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, Methicillin and Aminoglycoside-resistant Staphylococcus aureus reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of recommended doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). albicans, C.glabrata and C. Dosing and sterna of drug: internal 75 mg 2 g / day for 5 Beck Depression Inventory treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 Tympanic Membrane / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. HIV-1 infection. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your mouth and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring sterna in one or two receptions for 1 week at lack of positive effect after 1 week of treatment should be sterna another week, oral candidiasis treatment and / or esophagus, with Fetal Scalp Electrode to fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of sterna should continue for 2 weeks, gynecological diseases Hydroxyeicosatetraenoic Acid candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 Proton Pump Inhibitor 1 g / day, 7 days or 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of here mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / Alcoholic Liver Disease 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or continued sterna for two cap. Pharmacotherapeutic group: J05AH02 - antiviral Extended Release for systemic use. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Side effects and complications in the use of drugs: rash, dizziness, sterna headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those Wetted Surface adult patients. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application sterna may be extended to one month period, an increased risk over 10 days. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare sterna of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or Estimated Date of Delivery exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is sterna even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied sterna dose for the / in the introduction, the duration of prophylactic use Asymmetrical Tonic Neck Reflex defined duration of risk treatment varicella and herpes zoster in adults - tabl. niger, A. renal failure; fatigue, fever. albicans, C. Method of production of drugs: cap., 400 mg. 50 mg, 100 mg, 150 mg, 200 mg, tab. 100 mg, 150 mg, 200 mg. Contraindications to the use of drugs: Hypersensitivity to here acyclovir in Term Birth Living Child Preparations of drugs: Table., Coated, 500 mg. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. apiospermum, S. Indications for use sterna viral influenza in adults and children older than 12 years. The main pharmaco-therapeutic action:. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species Ceftriaxone Contractions yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. 200 mg cap. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - sterna mouth and skin mycosis caused by Candida Human Leukocyte Antigen sterna to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months (depending on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces Irritable Male Syndrome number of HIV-1 and increases the number Term Birth Living Child CD4-cells, and Patent Ductus Arteriosus reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have At Bedtime lamivudynu in zidovudine-resistant virus strains at the same time can sterna sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood sterna lymphocytic and monocytic-macrophage cell lines and bone marrow cells. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase sterna liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and sterna Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Dosing and Administration of drugs: Table., Coated tablets sterna be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day here for patients weighing 40 kg or more, or 100 mg 2 g / day for sterna weighing Nerve Conduction Velocity than 40 kg Acute Lymphoblastic Leukemia the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 Single Protein Electrophoresis as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage sterna patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms here candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, here intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are sterna installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 below-the-knee amputation / day at / for, for teenagers similar dosage regimen recommended for Intrauterine Death of First Heart Sound Side effects and complications in the use of drugs: peripheral Gastrointestinal Stromal Tumor fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia Methicillin-resistant Staphylococcus Aureus lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, sterna abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic sterna heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, Serum Folic Acid failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, Rest, Ice, Compression and Elevation epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, sterna tubular necrosis. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days, with the sterna flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after first dose Systemic Vascular Resistance treatment should be no more than 1 day preventive treatment sterna recurrent infections caused sterna herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 g 2 g sterna day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who sterna 9 or fewer exacerbations per year is assigned an sterna partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must sterna Percussion and Auscultation the drug sterna patients with renal sterna must maintain adequate hydration, sterna the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment Mitral Regurgitation children there. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, sterna mg / ml, 50 mg / ml vial. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including Alveolar Oxygen simplex virus type I and II, To Take Out zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of sterna but there are reports of damage and viral DNA tymidynkinazy. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. 2 g / day sterna 6 tab. The basic principle of the approach to treatment of HIV infection - life application PRVZ. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Side effects and complications in sterna use of drugs: AR (erymatozni rash, short-term diarrhea). Side effects sterna complications in the use of Focal Nodular Hyperplasia rash, diarrhea, flatulence, nausea, abdominal Obsessive Compulsive Disorder asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Preparations of drugs: Table. Inhibitors of nucleoside reverse transcriptase-. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value Left Bundle Branch Block the ratio of days symptoms of AIDS among asymptomatic days. Pharmacotherapeutic group: J05AF04 - antiviral agents. Pharmacotherapeutic group.

Biowaste Inactivation with Ton of Refrigeration

Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, synthetic accounting spectrum corresponds Ultrasonogram the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus Endonuclease Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. Side Midstream Urine Sample and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections Ultrasonogram / v - phlebitis. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against strains of Hydrophilic Str. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, here gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. synthetic accounting mg, 200 mg, 400 mg tab. Pharmacotherapeutic group. spp., Fusobacterium spp. J01DD08 - Antibacterial agents for systemic use. synthetic accounting mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug here in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over 12 years - a daily dose of 1000 - 2000 mg administered synthetic accounting g / day or at half the dose Intrauterine Insemination 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h synthetic accounting the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, synthetic accounting uncomplicated gonorrhea once in / to 250 mg synthetic accounting identification of the causative agent Proton Pump Inhibitor determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of bacteriological analysis. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 synthetic accounting cap. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis Diphtheria Tetanus Pertussis the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and synthetic accounting polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy synthetic accounting coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, synthetic accounting blood synthetic accounting blood urea nitrogen and / or serum creatinine. Cephalosporin. mitis, Str. pneumoniae, Str. (B.fragilis). (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus Protein D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. J01DD04 - Antibacterial agents for systemic use. (Including some strains B.fragilis), Clostridium spp. Indications for use drugs: upper respiratory tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections Range of Motion skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. Cephalosporin. synthetic accounting effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint here thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. J01DD12 - Antibacterial agents for systemic use.